Key facts
- This page summarizes Michael Macaluso's Form 4 filing for Ampio Pharmaceuticals, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Jan 2022, 17:31.
Michael Macaluso - 01 Jan 2022 Form 4 Insider Report for Ampio Pharmaceuticals, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 01 Jan 2022
- Net transaction value
- -$38,988
- SEC form
- 4
- Accepted by SEC
- 04 Jan 2022, 17:31:41 UTC
- Prior SEC filing
- 28 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel Stokely, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael Macaluso filed Form 4 for Ampio Pharmaceuticals, Inc. on 04 Jan 2022.
Change
- Previous filing in this sequence was filed on 28 Oct 2021.
- Current net transaction value: -$38,988.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMPE
transaction
Common Stock
Tax liability
- Transaction value
- $38,988
- Shares
- -68,400
- Change %
- -2.5%
- Price
- $0.5700
- Shares after
- 2,624,882
- Date
- 01 Jan 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.